Corporation X (CVC, listed on the First Section of Tokyo Stock Exchange (Prime Market)) v. Corporation Y
ABE & PARTNERS has advised Corporation X on investment agreement and drafted stock purchase agreement and shareholder's agreement.
Meeting your
business goals
together
We stand by always ready to provide
optimal strategies for your company
scroll
Topics
& News
open_in_new
Takanori ABE's article titled "Regimen patents in Japan: LCM failures and successes" had been published on LSIPR.
Takanori ABE published the article titled "Regimen patents: LCM failures and successes".
open_in_new
Takanori ABE's comment appeared in an article titled "Hydrogen patents shift to clean technologies" in Asia IP.
open_in_new
Takanori ABE will give a speech at the session "Amgen vs Sanofi/Regeneron" at Pharma & Biotech Patent Litigation Summit, Europe.
open_in_new
Takanori ABE will give a speech at the session "Japan, Pharma and Biotech Patent Litigation Case Law Review" at Pharma & Biotech Patent Litigation Summit, Europe.
Cases
U.S. IT Company X v. Y
ABE & PARTNERS has advised U.S. IT Company on Japanese laws and regulations.
Baxalta v. Chugai
Patent Infringement Lawsuit
Nichia Corporation v. Everlight Electronics
U.S. Patent Infringement Lawsuit
Takanori ABE's article titled "Takanori Abe reviews the litigation in Germany over Nichia's patent for a white LED" was cited in PETITION FOR WRIT OF CERTIORARI Nichia Corporation submitted to the U.S. Supreme Court.
Shire v. Japanese Pharmaceutical Company
ABE & PARTNERS represented Shire in M&A Due Diligence.
Publications
"[GUEST POST] Antitrust defense to patent infringement in Japan: IP High Court overruled Tokyo District Court in toner cartridge recycling case"
Source : FOSS PATENTS
"Why were Toyota, Honda, and GM sued by Intellectual Ventures? Connected cars and patent litigation"
Source : WIPR
"The Japanese view on FRAND"
Source : The SEP Couch with Tim Pohlmann
"Why the 'first penguin' of Pay for Delay has not come in Japan - Anatomy of a Japan Paradox -"
Source : ABA, Antitrust Law Section, Intellectual Property Committee, tidBITS
"Will authorised biologics deter biosimilars? Utilising JFTC’s expertise in drug pricing"
Source : Springer l OA CC BY-NC-ND 4.0 International License
“International IP
Law Firm of the Year”― ACQ Global Awards
Information
-
＜Caution＞
ABE & PARTNERS has received information that the name of our firm and atrorney from our office have been used to attempt to commit fraud.
If you receive any contact from an unknown person using the name of our office or an attorney from our office, do not respond immediately, but please fully confirm the identity of that person.
In addition, we would greatly appreciate your informing us by using "Contact".